Similar articles

• Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.

  Tseng PL, Wang JH, Tung HD, Hung CH, Kee KM, Chen CH, Chang KC, Lee CM, Changchien CS, Chen PF, Tsai LS, Lu SN. Tseng PL, et al. J Gastroenterol Hepatol. 2010 Aug;25(8):1426-34. doi: 10.1111/j.1440-1746.2010.06285.x. J Gastroenterol Hepatol. 2010. PMID: 20659234
• Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.

  Hussain K, El-Serag HB. Hussain K, et al. Minerva Gastroenterol Dietol. 2009 Jun;55(2):123-38. Minerva Gastroenterol Dietol. 2009. PMID: 19305372 Review.
• Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.

  Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T. Yamagiwa K, et al. J Gastroenterol Hepatol. 2008 Mar;23(3):482-90. doi: 10.1111/j.1440-1746.2007.05262.x. Epub 2007 Dec 13. J Gastroenterol Hepatol. 2008. PMID: 18086115
• Chemoembolization and bland embolization: a critical appraisal.

  Befeler AS. Befeler AS. Clin Liver Dis. 2005 May;9(2):287-300, vii. doi: 10.1016/j.cld.2004.12.011. Clin Liver Dis. 2005. PMID: 15831274 Review.
• Management of hepatocellular carcinoma in the age of liver transplantation.

  Martin AP. Martin AP. Int J Surg. 2009 Aug;7(4):324-9. doi: 10.1016/j.ijsu.2008.12.041. Epub 2009 Jan 6. Int J Surg. 2009. PMID: 19643691 Review.